HEALTHEQUITY, INC.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | BMO Capital | maintain | Outperform → Outperform | — | 53% |
| Sep 18, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 31, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Aug 28, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 24, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 3, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Jun 1, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| May 29, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 22, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Apr 9, 2026 | BMO Capital | upgrade | Market Perform → Outperform | — | 53% |
| Mar 19, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Mar 18, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Mar 18, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Mar 18, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Feb 18, 2026 | Barclays | maintain | Overweight → Overweight | $110 | 53% |
| Feb 17, 2026 | BTIG | maintain | Buy → Buy | $110 | 52% |
| Jan 9, 2026 | Goldman Sachs | downgrade | Neutral → Sell | $89 | 54% |
| Jan 8, 2026 | Keybanc | maintain | Overweight → Overweight | $125 | 52% |
| Dec 9, 2025 | Barclays | initiate | — → Overweight | $118 | 53% |
| Dec 4, 2025 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Dec 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $129 | 55% |
| Dec 4, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $122 | 47% |
| Dec 4, 2025 | BTIG | reiterate | Buy → Buy | $130 | 52% |
| Nov 13, 2025 | BMO Capital | initiate | — → Market Perform | $100 | 53% |
| Oct 8, 2025 | Keybanc | maintain | Overweight → Overweight | $120 | 52% |
| Sep 3, 2025 | Jefferies | maintain | Buy → Buy | $134 | 52% |
| Sep 3, 2025 | JP Morgan | maintain | Overweight → Overweight | $126 | 55% |
| Sep 3, 2025 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Sep 3, 2025 | RBC Capital | maintain | Outperform → Outperform | $110 | 55% |
| Aug 29, 2025 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Aug 28, 2025 | RBC Capital | maintain | Outperform → Outperform | $109 | 55% |
| Jul 8, 2025 | Raymond James | reiterate | Strong Buy → Strong Buy | $120 | 54% |
| Jun 11, 2025 | Jefferies | maintain | Buy → Buy | $130 | 52% |
| Jun 5, 2025 | Barrington Research | maintain | Outperform → Outperform | $125 | 56% |
| Jun 5, 2025 | Deutsche Bank | maintain | Buy → Buy | $115 | 57% |
| Jun 4, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $104 | 54% |
| Jun 4, 2025 | RBC Capital | maintain | Outperform → Outperform | $117 | 55% |
| Jun 4, 2025 | B of A Securities | maintain | Buy → Buy | $125 | 53% |
| Jun 4, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $117 | 53% |
| Apr 16, 2025 | Keybanc | maintain | Overweight → Overweight | $100 | 52% |
| Apr 11, 2025 | Barrington Research | maintain | Outperform → Outperform | $112 | 56% |
| Mar 27, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $94 | 54% |
| Mar 25, 2025 | Raymond James | upgrade | Outperform → Strong Buy | $115 | 54% |
| Mar 24, 2025 | Keybanc | maintain | Overweight → Overweight | $110 | 52% |
| Mar 20, 2025 | Deutsche Bank | maintain | Buy → Buy | $98 | 57% |
| Mar 19, 2025 | Barrington Research | maintain | Outperform → Outperform | $112 | 56% |
| Mar 14, 2025 | Barrington Research | maintain | Outperform → Outperform | $112 | 56% |
| Feb 26, 2025 | Wells Fargo | maintain | Overweight → Overweight | $125 | 54% |
| Feb 25, 2025 | Raymond James | maintain | Outperform → Outperform | $120 | 54% |
| Jan 14, 2025 | Deutsche Bank | maintain | Buy → Buy | $108 | 57% |
No cross-platform signals in the last 90 days